Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats.

Öz

Anahtar Kelimeler

• -

Anticarcinogenic activity of allylmercaptocaptopril against AflatoxinB1 induced liver carcinoma in rats.

Öz

-

Anahtar Kelimeler

• -

Kaynakça

1. Path FRC, Ali Abdel S. An update on the pathogenesis and pathology of Hepatocellular Carcinoma. Bah Med Bull 2007;29:1-8.
2. Asmaa IG, Shahid AK, Mireille BT, Imam W, Simon D, Robinson T. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World J of Gastroenterol 2008;14:4300-8.
3. Noore A, Monica R, Deborah B. Epidemiology of primary liver cancer. Cancer Forum 2009;33:1-5.
4. Daniel MK, Daniel ZV, Misael U, Nahum MS. Hepatocellular carcinoma: An overview. Annal Hep 2006;5:16-24.
5. William FW, Agostino M. Captopril as a chemopreventive agent. Free Patent Online 1993; Pt no.5192524.
6. Amitai E, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, MorOron H, Rosenthal T. The Effects of Allicin on Weight in Fructose-Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats. American J Hyper 2003;16:1053-6.
7. Miron T, Rabinkov A, Peleg E, et al. Allylmercaptocaptopril: a new antihypertensive drug. Am J Hypertens 2004; 17: 71-3.
8. Stoll A, Seebeck E. Die synthesis des naturlichen Aliins und senier drei optish aktiven Isomerasen. Hel Chem Acta 1948;31:189-210.

9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-Phenol reagents. J Biol Chem 1951;193:265-75.
10. Darrow RA, Colowick SP. Methods Enzymol 1962; 226-7.
11. Horrocks JE, Ward J, King JA. A routine method for the determination of phosphoglucoisomerase activity in body fluid. J Clin Pathol 1963;16: 248-52.
12. Bergmeyer HU. Methods of Enzymatic Analysis, Second Edition, 1974, Volume I, 430
13. Taussky HH, Shorr EJ. Biol Chem 1953; 202:675-85.
14. Nordlie, RC, Arion WJ. Methods Enzymology 1966;9:619- 25.
15. Gancedo JM, Gancedo C. Fructose 1,6-disphosphatase, phospho fructokinase and glucose-6-phosphate dehydro- genase from fermenting and non-fermenting yeasts. Arch Microbiol 1971;76:132-8.
16. Kamali M, Manhouri H. A Modified Orcinol Reaction for RNA Determination. Clin Chem 1969;15:390-2.
17. Burton K. A Study of the Conditions and Mechanism of the Diphenylamine Reaction for the Colorimetric Estimation of Deoxyribonucleic Acid. Biochem J 1956;62:315-23.
18. Bannasch P, Mayer D, Hacker HJ. Hepatocellular glyco- genesis and hepatocarcinogenesis. Biochim Biophys Acta 1980;605:217-45.
19. Hertzfeld A, Greengard O. Enzyme activities in human fe- tal and neoplastic tissues. Cancer 1980;46:2047-54.
20. Parry DM, Pedersen PL. Intracellular localization and properties of particulate hexokinase in the Novikoff asci- tes tumour. J Biol Chem 1983;258:10904-12.
21. Arora KK, Pedersen PL. Functional significance of mito- chondrial bound hexokinase in tumour cell metabolism. J Biol Chem 1988;263:17422-28.
22. Campbell DM, King, EJ. Serum phosphatases and glyco- lytic enzymes in cancer of the breast. Biochem J 1962; 82:23-8.
23. Hennipman A, Van Oirschot BA, Smits J, Rijksen G,Stacil GEJ. Heterogeneity of glycolytic enzyme activity and iso- zyme composition of pyruvate kinase in breast cancer. Tumour Biol 1988;9:178-88.
24. Quistorff, B. Gluconeogenesis in periportal and perive- nous hepatocytes of rat liver, isolated by a new high-yield digitonin/ collagenase perfusion technique. Biochem J 1985;229:221-6.
25. Graham MM, Spence AM, Muzi M, Abbot GL. Deoxyglucose kinetics in rat brain tumour. J CerebBlood Flow Metab 1989;9:315-22.
26. Weber G, Cantero A. Comparison of carbohydrate metab- olism in normal and neoplastic liver. EnzymeStudies. Acta Unio Internat Contra Cancrum 1960;16:1002.
27. Ellis EN, Burnette JJ, Sedlack R, Dyas C, Blackemore WSA. Surgery 1991;173:329.
28. Lancaster MC. Comparative Aspects of Aflatoxin-induced Hepatic Tumors. Cancer Research 1968; 28:2288-92.
29. Roebuck BD, Maxuitenko YY. In: Eaton DL, Groopman JD, editors. Toxicology of aflatoxins. San Diego: Academic Press, 1994:27-43.